Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trialJianxing He, Caicun Zhou, Lin Wu et al.|The Lancet Respiratory Medicine|2021Cited by 183
Hes1/Hes5 Gene Inhibits Differentiation via Down-Regulating Hash1 and Promotes Proliferation in Cervical Carcinoma CellsJia Liu, Xing Xie, Weiguo Lü et al.|International Journal of Gynecological Cancer|2010Cited by 23